Safety and Tolerability of Liraglutide in Healthy Male Volunteers

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Novo Nordisk A/S
ClinicalTrials.gov Identifier:
NCT01507272
First received: January 5, 2012
Last updated: January 23, 2017
Last verified: January 2017